HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.

Authors

Phil Zeitler
Kathryn Hirst
Kenneth C Copeland
Laure El Ghormli, George Washington University
Lorraine Levitt Katz
Lynne L Levitsky
Barbara Linder
Paul McGuigan
Neil H White
Denise Wilfley

Document Type

Journal Article

Publication Date

12-1-2015

Journal

Diabetes Care

Volume

38

Issue

12

Inclusive Pages

2285-2292

DOI

10.2337/dc15-0848

Keywords

Diabetes Mellitus, Type 2--drug therapy; Hemoglobin A, Glycosylated--analysis; Hypoglycemic Agents--therapeutic use

Comments

This is an open access publication. Click on link for full-text access.

APA Citation

Zeitler, P., Hirst, K., Copeland, K., El Ghormli, L., Levitt Katz, L., Levitsky, L., Linder, B., McGuigan, P., White, N., & Wilfley, D. (2015). HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.. Diabetes Care, 38 (12). http://dx.doi.org/10.2337/dc15-0848

Peer Reviewed

1